Literature DB >> 2095304

Surgical indications for infantile subdural effusion.

N Sakai1, H Nokura, K Deguchi, E Decarlini, A Futamura, H Yamada.   

Abstract

Thirty-four cases of infantile subdural effusion (ISE) were reviewed in relation to surgical treatment and its prognosis during an average of 4 years of extended follow-up. The surgical indications were determined mainly by the size of the ISE on computed tomography (CT) scan and by metrizamide CT cisternography (MCTC). Consequently, 18 cases were categorized as type A according to MCTC, including 11 cases (61.1%) of ISE CT grade 1. All type A cases were closely observed. This nontreatment regimen yielded excellent results in 15 cases (83.3%). For 10 cases categorized as type B according to MCTC, including 5 cases (50%) of ISE CT grade 3, surgical treatment was indicated and excellent results were obtained in 8 cases (80%). For 6 cases categorized as type C according to MCTC and as ISE CT grade 3, surgery yielded excellent results in 4 cases (66.7%). Antiepileptic drugs have been given to three (27.3%) of the 11 patients who had convulsive attacks. In conclusion, the surgical indications for ISE were based mainly on MCTC in addition to the clinical course, and it is emphasized that, in the early stages, surgery on ISE cases categorized as MCTC types B and C is necessary.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2095304     DOI: 10.1007/bf00302091

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

1.  Subdural effusions complicating bacterial meningitis.

Authors:  M H D SMITH; R E DORMONT; G W PRATHER
Journal:  Pediatrics       Date:  1951-01       Impact factor: 7.124

2.  Delayed onset of acute posttraumatic subdural effusion.

Authors:  F A Gutierrez; A J Raimondi
Journal:  Am J Dis Child       Date:  1974-09

3.  Results of nonoperative treatment in 15 cases of infantile subdural hematoma.

Authors:  R L McLaurin; E Isaacs; H P Lewis
Journal:  J Neurosurg       Date:  1971-06       Impact factor: 5.115

4.  Benign subdural collections of infancy.

Authors:  S Briner; J Bodensteiner
Journal:  Pediatrics       Date:  1981-06       Impact factor: 7.124

5.  Effect of temporary subdural-peritoneal shunt on subdural effusion with subarachnoid effusion.

Authors:  T Tsubokawa; S Nakamura; K Satoh
Journal:  Childs Brain       Date:  1984

6.  Benign subdural collections of infancy.

Authors:  W C Robertson; R W Chun; W W Orrison; J F Sackett
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

7.  The value of CSF flow studies in infants with communicating hydrocephalus.

Authors:  F Velardi; H J Hoffman; J M Ash; E B Hendrick; R P Humphreys
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

8.  Benign subdural effusion in infants.

Authors:  K Mori; H Handa; M Itoh; T Okuno
Journal:  J Comput Assist Tomogr       Date:  1980-08       Impact factor: 1.826

9.  Benign enlargement of the subarachnoid spaces in the infant.

Authors:  L R Ment; C C Duncan; R Geehr
Journal:  J Neurosurg       Date:  1981-04       Impact factor: 5.115

10.  Subdural hygroma: results of treatment by ventriculo-abdominal shunt.

Authors:  C J Njiokiktjien; J Valk; H Ponssen
Journal:  Childs Brain       Date:  1980
View more
  3 in total

1.  Early and delayed SPECT images of extracerebral fluid collection in infants using 123I-N-isopropyl-p-iodoamphetamine.

Authors:  R Shirane; S Satoh; A Ogawa; T Yoshimoto; S Maruoka
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

2.  Remote postoperative epidural hematoma after subdural hygroma drainage.

Authors:  Wellingson Silva Paiva; Arthur Maynart Pereira Oliveira; Almir Ferreira de Andrade; Roger Schmidt Brock; Manoel Jacobsen Teixeira
Journal:  Case Rep Med       Date:  2010-07-07

Review 3.  Benign external hydrocephalus: a review, with emphasis on management.

Authors:  Sverre Morten Zahl; Arild Egge; Eirik Helseth; Knut Wester
Journal:  Neurosurg Rev       Date:  2011-06-07       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.